Canon concluded a shares and other securities transfer agreement with Toshiba Corporation (“Toshiba”; Headquarters: Tokyo, Japan; President and CEO: Satoshi Tsunakawa) on March 17, 2016. See what's happening in the market right now with MarketBeat's real-time news feed. Louis Navellier & Matt McCall debate it and name their #1 picks — FREE.Will the DOW or Bitcoin Hit 40,000 in the Next 12 Months?Dupixent has a growing addressable market. "The P/E ratio of Canon is 17.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.93.Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.Canon has a PEG Ratio of 22.68. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.Earnings for Canon are expected to grow by 25.29% in the coming year, from $0.87 to $1.09 per share.Canon has only been increasing its dividend for 2 years.CAJ stock was sold by a variety of institutional investors in the last quarter, including Cardinal Capital Management, M&T Bank Corp, and Investors Research Corp.Sign-up to receive the latest news and ratings for CAJ and its competitors with MarketBeat's FREE daily newsletter.Canon is a leading dividend payer. Although a higher dosage benefited patients, the side effects on the higher dosage are not clear.Regeneron continues to develop drugs in the oncology market. Additionally, by making use of Canon’s business portfolio and partnerships, further progress is expected in the field of medical equipment.A collaborated effort between Canon, with its advanced production technologies, and Toshiba Medical, with its exceptional product development capabilities, is expected to lead to further enhancing Toshiba Medical’s product strength through the provision of precision design and microfabrication technologies, an optimized production system and cooperation aimed at improving quality. View the latest market news and prices, and trading information. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Only 1.18% of the stock of Canon is held by institutions.Identify stocks that meet your criteria using seven unique stock screeners. CAJ has a beta of 0.42, meaning it tends to be less sensitive to market movements. The company will also make prompt disclosure when something that needs to be made public occurs.Under Phase V of its Excellent Global Corporation Plan, a five-year initiative launched in 2016, Canon aims to embrace the challenge of new growth through a grand strategic transformation. AIVITA Biomedical has raised $31.20 m in total funding.
Crispr is currently focusing on chronic diseases like diabetes.Financial Market Data powered by FinancialContent Services, Inc. All rights reserved. CAJ has a correlation of 0.21 to the broad based SPY ETF. And markets like what the future holds.There are seven biotechnology stocks in 2020 that investors should hone in on. Following that, in order for Toshiba Medical to become a subsidiary, Canon sought clearance from competition regulatory authorities. As for the impact this will have on the company’s performance, in cases where the company needs to revise its projection it will make prompt disclosure. The government is starting to realize that high healthcare costs are not due solely to rising drug prices. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist.Learn everything you need to know about successful options trading with this three-part video course.Looking for new stock ideas? The technology company earns $1.15 billion in net income (profit) each year or $1.06 on an earnings per share basis. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Canon has a market capitalization of $18.51 billion and generates $32.67 billion in revenue each year. The company provided earnings per share (EPS) guidance of for the period. Find the latest Brickell Biotech, Inc. (BBI) stock quote, history, news and other vital information to help you with your stock trading and investing. This will not only enable the sale of price-competitive products in the market, but also contribute to the development of the health care business through the circulation of funds generated through enhanced management efficiency applied toward investing in the development of next-generation medical equipment.Canon possesses proprietary high-speed dynamic X-ray imaging sensor technology, among other imaging devices, along with associated elemental technologies; photoacoustic tomography technology selected by Japan’s national ImPACT program; medical robotic system technologies and minimally invasive technologies.